Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Clare

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
International Journal of Cardiology|November 21, 2015
Frequency, clinical and angiographic characteristics, and outcomes of high-risk non-ST-segment elevation acute coronary syndromes patients with left circumflex culprit lesionsSharif A Halim, Robert M Clare, L Kristin Newby, et al.
JACC. Heart Failure|March 14, 2014
Heart failure complicating non-ST-segment elevation acute coronary syndrome: timing, predictors, and clinical outcomesMaria Cecilia Bahit, Renato D Lopes, Robert M Clare, et al.
European Journal of Heart Failure|May 15, 2024
On-treatment analysis of torsemide versus furosemide for patients hospitalized for heart failure: A post-hoc analysis of TRANSFORM-HFVeraprapas Kittipibul, Robert J Mentz, Robert M Clare, et al.
JAMA|November 17, 2014
Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarctionDuk-Woo Park, Robert M Clare, Phillip J Schulte, et al.
Medrxiv : the Preprint Server for Health Sciences|August 16, 2024
Association of Cardiologist Clinic Visits with Cardiovascular Primary Prevention Outcomes Among People with HIV from Underrepresented Racial and Ethnic Groups in the Southern United StatesMatthew S Durstenfeld, C Larry Hill, Robert M Clare, et al.
American Heart Journal|June 4, 2018
Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysisBenjamin M Scirica, Sameer Bansilal, Farideh Davoudi, et al.
The American Journal of Cardiology|March 18, 2015
Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial)Jan H Cornel, Pierluigi Tricoci, Yuliya Lokhnygina, et al.
Circulation|May 22, 2023
Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical TrialStephen J Greene, Eric J Velazquez, Kevin J Anstrom, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 15, 2014
Predictors of contemporary coronary artery bypass grafting outcomesRichard D Weisel, Nancy Nussmeier, Mark F Newman, et al.
Journal of Cardiac Failure|July 21, 2023
Morbidity and Mortality Associated With Heart Failure in Acute Coronary Syndrome: A Pooled Analysis of 4 Clinical TrialsNathan P Goodwin, Robert M Clare, Josephine L Harrington, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
International Journal of Cardiology|November 21, 2015
Frequency, clinical and angiographic characteristics, and outcomes of high-risk non-ST-segment elevation acute coronary syndromes patients with left circumflex culprit lesionsSharif A Halim, Robert M Clare, L Kristin Newby, et al.
JACC. Heart Failure|March 14, 2014
Heart failure complicating non-ST-segment elevation acute coronary syndrome: timing, predictors, and clinical outcomesMaria Cecilia Bahit, Renato D Lopes, Robert M Clare, et al.
European Journal of Heart Failure|May 15, 2024
On-treatment analysis of torsemide versus furosemide for patients hospitalized for heart failure: A post-hoc analysis of TRANSFORM-HFVeraprapas Kittipibul, Robert J Mentz, Robert M Clare, et al.
JAMA|November 17, 2014
Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarctionDuk-Woo Park, Robert M Clare, Phillip J Schulte, et al.
Medrxiv : the Preprint Server for Health Sciences|August 16, 2024
Association of Cardiologist Clinic Visits with Cardiovascular Primary Prevention Outcomes Among People with HIV from Underrepresented Racial and Ethnic Groups in the Southern United StatesMatthew S Durstenfeld, C Larry Hill, Robert M Clare, et al.
American Heart Journal|June 4, 2018
Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysisBenjamin M Scirica, Sameer Bansilal, Farideh Davoudi, et al.
The American Journal of Cardiology|March 18, 2015
Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial)Jan H Cornel, Pierluigi Tricoci, Yuliya Lokhnygina, et al.
Circulation|May 22, 2023
Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical TrialStephen J Greene, Eric J Velazquez, Kevin J Anstrom, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 15, 2014
Predictors of contemporary coronary artery bypass grafting outcomesRichard D Weisel, Nancy Nussmeier, Mark F Newman, et al.
Journal of Cardiac Failure|July 21, 2023
Morbidity and Mortality Associated With Heart Failure in Acute Coronary Syndrome: A Pooled Analysis of 4 Clinical TrialsNathan P Goodwin, Robert M Clare, Josephine L Harrington, et al.
Pageof 6